BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Total Revenue

Revenue analysis for CSCI.

Quarterly Revenue

$2.75M
↑ 17.63% YoY

As of Jun 2025

Annual Revenue (TTM)

$9.44M
↑ 22.07% YoY

Trailing 12 months ending Jun 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin